Mumbai Company to Launch Eye Drops for Presbyopia

India is set to revolutionize eye care with the introduction of PresVu eye drops. This innovative treatment, developed by Mumbai’s Entod Pharmaceuticals, aims to reduce the need for reading glasses. Approved by the Drug Controller General of India (DCGI), PresVu is expected to be available in early October 2024.

PresVu eye drops are designed to tackle presbyopia, an age-related condition that makes it hard to focus on close objects. This issue usually starts in the early 40s and causes gradual vision decline, leading many people to rely on reading glasses. About one-third of adults in India experience this condition. PresVu aims to provide a new solution by helping people with mild to moderate presbyopia regain their visual independence.

PresVu eye drops contain pilocarpine hydrochloride, a natural compound that's been used for years to treat eye problems and dry mouth. These drops are meant for daily use and provide several hours of improved vision, so users can read and do other close-up tasks without glasses. According to the company, you'll start noticing results within 15 minutes, but it takes about 15 days of use to experience the full benefits.

PresVu is set to make a big difference in India, where presbyopia is becoming more common. According to reports, each vial will cost Rs 345, offering an affordable alternative to reading glasses. Since each vial lasts about a month, it provides a budget-friendly option for long-term use.

ALSO READ: The Power of Rituals: Small Daily Habits That Transform Your Health